Stanford Discovers Drug That Regenerates Worn Cartilage

For the 20% of American adults living with osteoarthritis, a Stanford Medicine discovery offers something that seemed impossible: the ability to regrow damaged cartilage.

Researchers identified the culprit behind age-related cartilage loss. A protein called 15-PGDH increases as we get older, preventing our bodies from repairing damaged joints, muscles, nerves, and organs.

The Stanford team tested what would happen if they blocked this protein in older mice. They injected an inhibitor both into the abdomen and directly into joints like the knee.

The results stunned even the scientists themselves. "Cartilage regeneration to such an extent in aged mice took us by surprise," says Nidhi Bhutani, senior author of the study. "The effect was remarkable."

The treatment worked differently than expected. Instead of relying on stem cells to create new cartilage, existing cells in the joint simply started acting younger, switching their gene expression patterns back to a more youthful state.

Athletes with ACL tears have even more reason to celebrate. Around 50% of people who suffer these injuries develop osteoarthritis within 15 years, but the protein blocker substantially reduced those odds in the study.

The Bright Side

Until now, no drug could directly treat the root cause of cartilage loss. People facing joint replacement surgery or living with chronic pain had few options beyond managing symptoms.

This discovery changes that equation entirely. The treatment addresses why cartilage stops regenerating in the first place, rather than just masking the pain.

Phase 1 clinical trials of the inhibitor have already shown it's safe in healthy volunteers when tested for muscle weakness. Bhutani's team hopes similar trials for cartilage regeneration in humans will launch soon.

"Imagine regrowing existing cartilage and avoiding joint replacement," Bhutani says. For millions facing limited mobility and constant discomfort as they age, that imagination is becoming closer to reality.

The breakthrough offers hope not just for the elderly but for anyone whose joints have taken a beating from sports, injuries, or simply living an active life.